131 related articles for article (PubMed ID: 29473835)
21. Clinicoprognostic Study of Hydroa Vacciniforme-like Lymphoproliferative Diseases: A Systematic Review.
Kim YJ; Yang HJ; Won CH; Chang SE; Lee MW; Lee WJ
Dermatology; 2023; 239(5):700-711. PubMed ID: 37231869
[TBL] [Abstract][Full Text] [Related]
22. Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma.
Chen HH; Hsiao CH; Chiu HC
Br J Dermatol; 2002 Sep; 147(3):587-91. PubMed ID: 12207607
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus-associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions.
Cho KH; Kim CW; Heo DS; Lee DS; Choi WW; Rim JH; Han WS
Clin Exp Dermatol; 2001 May; 26(3):242-7. PubMed ID: 11422165
[TBL] [Abstract][Full Text] [Related]
24. [Hydroa vacciniforme-like cutaneous T cell lymphoma: a case report and literature review].
Li HY; Wang HL; Gao TZ; Zhuo ZH; Li DM; Li HX
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):596-8. PubMed ID: 19651001
[TBL] [Abstract][Full Text] [Related]
25. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.
Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY
Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721
[TBL] [Abstract][Full Text] [Related]
26. Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course.
Park S; Lee DY; Kim WS; Ko YH
Am J Dermatopathol; 2010 Dec; 32(8):832-6. PubMed ID: 20595887
[TBL] [Abstract][Full Text] [Related]
27. Hydroa vacciniforme-like Epstein-Barr virus-associated lymphoproliferative disease: a case report.
Zeng Y; Fu L; Jin H; Sun Q; Wang B
Pediatr Dermatol; 2012; 29(1):96-100. PubMed ID: 21995788
[TBL] [Abstract][Full Text] [Related]
28. Chronic active Epstein-Barr virus infection-associated hydroa vacciniforme-like eruption and Behçet's-like orogenital ulcers.
Park BM; Ahn JS; Lee JB; Won YH; Yun SJ
Dermatology; 2013; 226(3):212-6. PubMed ID: 23751255
[TBL] [Abstract][Full Text] [Related]
29. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
30. Antiviral treatment of a boy with EBV-associated hydroa vacciniforme.
Pahlow Mose A; Fisker N; Clemmensen O; Bygum A
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25422336
[TBL] [Abstract][Full Text] [Related]
31. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up.
Verneuil L; Gouarin S; Comoz F; Agbalika F; Creveuil C; Varna M; Vabret A; Janin A; Leroy D
Br J Dermatol; 2010 Jul; 163(1):174-82. PubMed ID: 20367637
[TBL] [Abstract][Full Text] [Related]
33. Hydroa vacciniforme present for 48 years with cytotoxic CD4+ T-cell infiltration and Epstein-Barr virus infection.
Xie JL; Chen GY; Jin Y; Zheng XD; Wei XJ; Zheng YY; Zhang SH; Zhang YN; Zhang XJ; Zhou XG
Br J Dermatol; 2012 Feb; 166(2):449-51. PubMed ID: 21801161
[No Abstract] [Full Text] [Related]
34. Antiviral therapy in children with hydroa vacciniforme.
Lysell J; Wiegleb Edström D; Linde A; Carlsson G; Malmros-Svennilson J; Westermark A; Andersson J; Wahlgren CF
Acta Derm Venereol; 2009; 89(4):393-7. PubMed ID: 19688153
[TBL] [Abstract][Full Text] [Related]
35. Hydroa vacciniforme with oral mucosal involvement.
Yesudian PD; Sharpe GR
Pediatr Dermatol; 2004; 21(5):555-7. PubMed ID: 15461761
[TBL] [Abstract][Full Text] [Related]
36. An elderly patient with chronic active Epstein-Barr virus infection with severe hydroa vacciniforme-like eruptions associated with αβT-cell proliferation.
Nomura H; Egami S; Kasai H; Mori M; Yokoyama T; Fujimoto A; Sugiura M; Iwatsuki K
J Dermatol; 2014 Apr; 41(4):360-2. PubMed ID: 24628134
[No Abstract] [Full Text] [Related]
37. Hydroa vacciniforme with latent Epstein-Barr virus infection.
Ohtsuka T; Okita H; Otsuka S; Yamakage A; Yamazaki S
Br J Dermatol; 2001 Sep; 145(3):509-10. PubMed ID: 11531850
[No Abstract] [Full Text] [Related]
38. EBV-associated hydroa vacciniforme-like T-cell lymphoma.
Roy SF; Ghazawi FM; Powell J; Kokta V; Bélisle A
Br J Haematol; 2019 Sep; 186(6):802. PubMed ID: 31218678
[No Abstract] [Full Text] [Related]
39. A rare case of hydroa vacciniforme-like cutaneous T-cell lymphoma presenting mimicking herpes simplex in an adult.
Wang T; Wang L; Xiong L; Han M; Liu W; Li G
Am J Dermatopathol; 2013 Jul; 35(5):617-8. PubMed ID: 23782639
[No Abstract] [Full Text] [Related]
40. Cutaneous T-cell lymphoma presenting as a ten month history of unilateral facial swelling.
Cotter A; Treacy A; O'Keane C; Mulligan N; Lambert J
Ir Med J; 2008 May; 101(5):151-2. PubMed ID: 18624265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
